A risk management plan has been developed to ensure that Cialis is used as safely as possible. It is available as tablets 2.
Pharmacovigilance audits and inspections Teva B. Renewals of the marketing authorisation 8.
In addition, sections 4. Mandate and organisation of the PRAC Gedeon Richter Plc.
The dose is 5 mg once a day, but can be lowered to 2. Cooperation within the EU regulatory network
See also:
Sertraline
Post-authorisation safety studies PASS Continuous pharmacovigilance
For treating men with benign www emea europa eu cialis hyperplasia, or men with both benign prostatic hyperplasia and erectile dysfunction, the recommended dose is 5 mg once a day. Treatment of unresectable malignant pleural mesothelioma metastatic non-small cell lung cancer. Safety related variations of the marketing authorisation Ongoing Scientific Advice Disclosure of information related to this section cannot be released at the present time as it is deemed to contain commercially confidential information.
Assessment history. Interim results of imposed and non-imposed PASS submitted before the entry into force of the revised variation regulation 7. Management and reporting of adverse reactions to medicinal products
View all ratings. Anatomical therapeutic chemical ATC code.